Related Experiment Video
Updated: Jun 2, 2026

12:10
Retzius-Sparing Robot-Assisted Radical Prostatectomy
Published on: May 19, 2022
Robotic-assisted radical prostatectomy using the Toumai system: initial single-center experience in Morocco
Rajaa Et-Touzani1, Imane Aoid2, Jaafar Zemrag2
1Department of Urology, Centre Hospitalier Universitaire de Dijon-Bourgogne, Dijon, 21000, France.
Journal of Robotic Surgery
|June 1, 2026
Summary
Robot-assisted radical prostatectomy (RARP) using the Toumai system is feasible and safe in Morocco. Early functional outcomes show promising continence and potency rates, warranting further investigation.
Area of Science:
- Urology
- Robotic Surgery
- Surgical Technology
Background:
- Robotic surgery is expanding in Morocco, particularly in urology.
- Robot-assisted radical prostatectomy (RARP) offers potential benefits for prostate cancer treatment.
Purpose of the Study:
- To evaluate the feasibility, safety, and early outcomes of RARP using the novel Toumai MT-1000 system.
- To assess perioperative, pathological, and functional results in a Moroccan tertiary care setting.
Main Methods:
- Prospective study of 132 consecutive patients undergoing RARP with the Toumai system.
- Standardized transperitoneal anterior approach performed by a single experienced surgeon.
- Analysis of perioperative data, pathological outcomes, and early functional results (continence, potency) with a minimum 3-month follow-up.
Main Results:
- Median operative time was 155 minutes with a median blood loss of 126 mL.
- Low rates of complications (6%) and positive surgical margins (6%).
- Continence rates reached 92% at 3 months; 35% of assessed patients achieved potency (IIEF-5 score ≥17) at 3 months.
Conclusions:
- Toumai-assisted RARP is feasible in a high-volume Moroccan center.
- Early functional outcomes are encouraging, suggesting the system's potential.
- Preliminary findings necessitate multicenter studies with longer follow-up for confirmation.
